ASH 2020: Risks of Venous Thromboembolism Recurrence and Bleeding in Cancer Patients Treated With Direct Oral Anticoagulants Can Be Overcome
In setting of careful patient selecting, risks were similar to those of standard therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.